Cargando…
Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro
BACKGROUND: To explore the anti-tumor effects of parthenolide in human pancreatic cancer. METHODS: BxPC-3 cell, a human pancreatic cancer, was treated with parthenolide at different concentrations. The MTT assay was used to analyze cell viability. Flow cytometry and DNA fragmentation analysis were a...
Autores principales: | Liu, Jun-Wei, Cai, Min-Xia, Xin, Ying, Wu, Qing-Song, Ma, Jun, Yang, Po, Xie, Hai-Yang, Huang, Dong-Sheng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924280/ https://www.ncbi.nlm.nih.gov/pubmed/20698986 http://dx.doi.org/10.1186/1756-9966-29-108 |
Ejemplares similares
-
Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
por: Liu, Weifeng, et al.
Publicado: (2017) -
Parthenolide Induces Apoptosis and Cell Cycle Arrest of Human 5637 Bladder Cancer Cells In Vitro
por: Cheng, Guang, et al.
Publicado: (2011) -
Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
por: Yi, Juan, et al.
Publicado: (2022) -
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
por: Jorge, Joana, et al.
Publicado: (2023) -
Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022)